Nano‐Curcumin for Cancer Therapy: A Strategic Approach to Improve Bioavailability and Modulate Tumor Resistance
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202502012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Neha V Rathod und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Bioengineering, Institute of Advanced Research Gandhinagar, Gandhinagar, India. Hauptthemen laut MEDLINE: Curcumin, Neoplasms, Drug Resistance, Neoplasm, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 207 Literaturangaben.
Abstract (Originalsprache)
Curcumin, the primary bioactive compound found in Curcuma longa , has exhibited significant anticancer properties by promoting apoptosis, curbing cell proliferation, and influencing various oncogenic signaling pathways. Although curcumin holds significant therapeutic promise, its clinical application is hindered by its naturally low water solubility, rapid metabolic breakdown, and limited systemic bioavailability. The pharmacokinetic challenges, coupled with the complex nature of tumor microenvironments and the multidrug resistance (MDR) present in cancer cells, necessitate advanced drug delivery methods. Nanotechnology offers promising solutions to these challenges by facilitating the design of curcumin‐loaded nanocarriers that improve solubility, stability, tumor‐targeting capabilities, and provide sustained release profiles. This review thoroughly explores the various nanoformulation (NF) approaches that have been employed to improve curcumin's anticancer potency, such as polymeric nanoparticles, solid lipid nanoparticles (SLNs), liposomes, micelles, and dendrimers. The main emphasis is on their design, targeting strategies, and potential to boost tumor penetration and overcome MDR. Stimulus‐responsive and ligand‐targeted nano‐curcumin formulations that interact to the tumor microenvironment and enhance therapeutic precision are also covered in this review. To demonstrate the translational potential and safety profiles of various NFs, preclinical and emerging clinical evidence are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Bioengineering, Institute of Advanced Research Gandhinagar, Gandhinagar, India.
ORCID-Profile: Satyendra Mishra
Zitieren
APA
Rathod, N. V., & Mishra, S. (2025). Nano‐Curcumin for Cancer Therapy: A Strategic Approach to Improve Bioavailability and Modulate Tumor Resistance. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202502012
Vancouver
Rathod NV, Mishra S. Nano‐Curcumin for Cancer Therapy: A Strategic Approach to Improve Bioavailability and Modulate Tumor Resistance. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202502012
BibTeX
@article{Rathod2025,
author = {Rathod, Neha V and Mishra, Satyendra},
title = {Nano‐Curcumin for Cancer Therapy: A Strategic Approach to Improve Bioavailability and Modulate Tumor Resistance},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202502012}
}
EUVIMED